Target intelligence / Profile preview

MAF BZIP transcription factor G (MAFG)

Target
MAFG
Molecular classification
Transcription factor, Basic leucine zipper (bZIP) family, Small Maf protein
01

Overview

MAFG is a small Maf family transcription factor (~160 amino acids, ~18 kDa) featuring a basic leucine zipper (bZIP) domain for DNA binding and dimerization. It forms homodimers (which act as transcriptional repressors) and heterodimers with CNC proteins such as Nrf2, Nrf1, and Nrf3, and Bach proteins, which can either activate or repress transcription depending on the partner and cellular context. In particular, Nrf2-MAFG heterodimers regulate cellular antioxidant response via binding to the antioxidant response element (ARE), and play a crucial role in protecting cells from oxidative stress and in controlling globin gene expression in erythroid cells. MAFG lacks a transactivation domain and is indispensable for the function of CNC family proteins because these cannot bind DNA or regulate transcription alone; thus, MAFG is a core component for the regulation of multiple cellular stress responses, erythropoiesis, and other gene regulatory networks.

Other names
Transcription factor MafGMAFGMGC13090MGC20149V-maf musculoaponeurotic fibrosarcoma oncogene homolog GhMAFBasic leucine zipper transcription factor MafGv-maf avian musculoaponeurotic fibrosarcoma oncogene homolog G
02

Mechanism of action

No drugs directly target MAFG. Drugs acting on Nrf2 (such as dimethyl fumarate) induce antioxidant response element (ARE) genes by facilitating Nrf2-MAFG heterodimer binding to DNA and initiating transcription of cytoprotective genes

03

Biological functions

DNA-binding transcription factor activityProtein heterodimerization activityTranscriptional repression (as homodimer)Transcriptional activation (as heterodimer)Regulation of gene expression in response to oxidative stress (via Nrf2)Regulation of globin gene expression in erythropoiesis
04

Disease associations

CancerHomocystinuria-megaloblastic anemia (Cble type)Ayme-Gripp syndromeOther: implicated in stress response and possibly neurodegenerative diseases through Nrf2 pathways
05

Safety considerations

No specific safety concerns associated with MAFG targeting established, but dysregulation of the MAFG/Nrf2 pathway may contribute to carcinogenesis and affect cellular antioxidant balance, raising theoretical risks
06

Interacting drugs

No approved drugs directly target MAFG; however, several Nrf2 pathway modulators (e.g., dimethyl fumarate, bardoxolone methyl) indirectly affect MAFG by modulating its heterodimer partner Nrf2, which controls MAFG induction as part of the antioxidant response
07

Biomarkers

Expression of MAFG and its target genes (e.g., NFE2L2/NRF2-induced genes) may serve as biomarkers in oxidative stress, cancer prognosis, and efficacy monitoring for Nrf2-activating drugs

Beyond the preview

Go deeper on MAF BZIP transcription factor G (MAFG).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MAF BZIP transcription factor G (MAFG).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call